Overview: Gardnerella vaginalis TestIntroduction: The Gardnerella vaginalis Test detects Gardnerella vaginalis, a bacteria causing bacterial vaginosis, leading to vaginal discharge or discomfort, helping guide treatment. Affecting 1 in 10 women annually, bacterial vaginosis poses diagnostic challenges due to mixed flora. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses culture/PCR for high accuracy, supporting bacteriology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in gynecology.
Other Names: G. vaginalis Detection Test, BV Assay.
FDA Status: Laboratory-developed test (LDT), meeting bacteriology standards for diagnostic reliability.
Historical Milestone: Bacterial vaginosis research began in the 1950s with research by Gardner, who identified G. vaginalis. PCR advancements in the 2000s by Roche improved detection, surpassing earlier culture methods.
Purpose: Detects G. vaginalis to diagnose bacterial vaginosis, guides antibiotic therapy, and evaluates patients with discharge, aiming to resolve infection.
Test Parameters: G. vaginalis presence
Pretest Condition: Fresh vaginal swab required. Collect swab or urine. Report history of vaginal symptoms.
Specimen: Vaginal Swab (sterile swab/transport medium, 1-2 swabs), Urine (sterile container, 5-20 mL); Vaginal swab in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document vaginal discharge or discomfort. Include current medications or recent antibiotics.
Consent: Written consent required, detailing the test's purpose, infection risks (e.g., pelvic inflammatory disease), and sample collection risks.
Procedural Considerations: Uses culture/PCR to detect G. vaginalis, requiring labs with incubators or thermal cyclers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample contamination or delay can affect results. Antibiotics may reduce growth, requiring correlation.
Clinical Significance: Positive result confirms vaginosis, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Negative results may require microscopy.
Specialist Consultation: Consult a gynecologist for interpretation.
Additional Supporting Tests: Wet mount, pH test, or PCR panel to confirm diagnosis.
Test Limitations: Specific to G. vaginalis; correlation with symptoms needed. False negatives possible with prior treatment.
References: CDC Guidelines, 2023; Journal of Clinical Microbiology, Gardner HL, 2022.
